An association between high circulating IGF1 and breast cancer risk has been demonstrated fairly consistently among premenopausal, but not postmenopausal, women have been inconsistent. Nevertheless, a recent pooled analysis found a
significantly increased risk of breast cancer with elevated IGF1 and IGFBP3 in postmenopausal women